The New QMS Normal

Top life science experts share best practices on how to leverage quality and compliance tools for a smooth and cost effective technology transformation.

You’ll walk away with a brand new QMS technology playbook, consisting of insights and recommendations you can use immediately.

Limited to 100 attendees!
Dec 8, 2020 // 03:30pm AEDT

Rethinking quality, compliance, and technology

Meet our experts panel

The life science industry was already in the midst of a technology transformation when COVID-19 hit.


Now, more than ever before, mid-sized heavily regulated life science organizations need end to end QMS solutions that can be quickly deployed, while continuing to mitigate risk and support business continuity.

We are sharing everything we learned to help you achieve a smooth technology transformation that mitigates risk and supports business continuity.

We’ll discuss some of the main impacts of COVID-19 on life science companies with a focus on end to end QMS solutions.

Limited to 100 attendees

You'll gain insights and recommendations on the best tools and capabilities you need to maintain compliance, to achieve growth, and to meet business goals.

Dec 8, 2020 // 03:30pm AEDT
Gal Haselkorn
VP Sales at Dot Compliance

Gal is an expert in Quality Management Systems technology in highly regulated industries and has worked with many life science companies implementing compliance systems from small startups to enterprise companies.


He has a proven track record in leading technology organizations for more than 25 years.

Like everyone else, we’ve learned a lot from the newly imposed challenges

You’re not alone. Join us to get the best prescriptive on the technological landscape of end to end quality and compliance solutions to continue growing during this period of disruption.

Franziska Loehrer
Director Quality & Deputy CEO at Scientia Clinical Research

Franziska is a clinical operations and quality professional with 25 years’ experience in the pharmaceutical industry predominantly in Phase 1 clinical research in Switzerland and Australia.

Since 2015 Franziska acts as the Director Quality and Deputy CEO of Scientia Clinical Research (SCR. As part of her role, she joined to assist in the implementation of the new facility with special focus on the development of the QMS.

Franziska is also Director and founder of Wahoo Clinical and has been a Lecturer at the UNSW School of Medicines for 20 years. Before that, worked at GSK and Novartis Pharma.

Bryan Tan
Director APAC Healthcare and Life Sciences at Salesforce

Dr Bryan Tan recently joined Salesforce's Healthcare & Life Sciences team with a background of clinical medicine, research, health informatics and strategy. His role in Salesforce provides clients with a forward-facing view on new models of healthcare with a focus on systems of engagement that enable organisations and ultimately patients improve their outcomes - clinical, operational, and the journey experience. 

Prior to joining Salesforce, Dr Tan held Executive roles at Cerner Corporation, McKinsey & Company and Roche Pharmaceuticals.

Meet our webinar team



How to overcome the newly imposed challenges by COVID  in the short term and long term?


How to achieve 

business continuity in 2020 and beyond with critical cloud solutions? 


How to accelerate your digitization efforts with tools that deliver immediate impact with minimum capital investment?


How to leverage Salesforce - the leading platform for life science and Helthcare organizations?

Make your transition the right way

Our panel of Healthcare and Life Science experts will share with you insights and recommendations you can use immediately.

Register to our webinar